William W.  Ericson net worth and biography

William Ericson Biography and Net Worth

William Ericson has been a member of our Board of Directors since 2004. Mr. Ericson is a Founding Partner at Wildcat Venture Partners where he focuses on investments in Digital Health. He is also a General Partner at Mohr Davidow Ventures (MDV) where he has led the firm’s focus on personalized medicine investing since 2003.

Mr. Ericson holds a B.S.F.S. from Georgetown University School of Foreign Service and a J.D. from Northwestern University School of Law. We believe that Mr. Ericson possesses specific attributes that qualify him to serve as a member of our Board of Directors, including his experience with multiple companies in the life sciences industry and his focus on companies with molecular diagnostic platforms that will enable the vision of personalized medicine.

What is William W. Ericson's net worth?

The estimated net worth of William W. Ericson is at least $71,608.95 as of March 15th, 2023. Mr. Ericson owns 18,795 shares of Pacific Biosciences of California stock worth more than $71,609 as of March 28th. This net worth approximation does not reflect any other investments that Mr. Ericson may own. Learn More about William W. Ericson's net worth.

How do I contact William W. Ericson?

The corporate mailing address for Mr. Ericson and other Pacific Biosciences of California executives is 1305 O`BRIEN DRIVE, MENLO PARK CA, 94025. Pacific Biosciences of California can also be reached via phone at (650) 521-8000 and via email at [email protected]. Learn More on William W. Ericson's contact information.

Has William W. Ericson been buying or selling shares of Pacific Biosciences of California?

William W. Ericson has not been actively trading shares of Pacific Biosciences of California during the past quarter. Most recently, William W. Ericson sold 7,541 shares of the business's stock in a transaction on Wednesday, March 15th. The shares were sold at an average price of $8.90, for a transaction totalling $67,114.90. Following the completion of the sale, the director now directly owns 18,795 shares of the company's stock, valued at $167,275.50. Learn More on William W. Ericson's trading history.

Who are Pacific Biosciences of California's active insiders?

Pacific Biosciences of California's insider roster includes (Pres), William Ericson (Director), Peter Fromen (Insider), Susan Kim (CFO), Kathy Ordonez (Director), and Mark Van Oene (COO). Learn More on Pacific Biosciences of California's active insiders.

Are insiders buying or selling shares of Pacific Biosciences of California?

During the last year, Pacific Biosciences of California insiders bought shares 1 times. They purchased a total of 40,000 shares worth more than $176,000.00. During the last year, insiders at the biotechnology company sold shares 9 times. They sold a total of 219,637 shares worth more than $1,971,923.77. The most recent insider tranaction occured on March, 6th when Director David W Meline bought 40,000 shares worth more than $176,000.00. Insiders at Pacific Biosciences of California own 1.9% of the company. Learn More about insider trades at Pacific Biosciences of California.

Information on this page was last updated on 3/6/2024.

William W. Ericson Insider Trading History at Pacific Biosciences of California

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2023Sell7,541$8.90$67,114.9018,795View SEC Filing Icon  
5/25/2021Sell37,500$25.89$970,875.0012,500View SEC Filing Icon  
8/19/2014Buy39,299$5.14$201,996.86View SEC Filing Icon  
8/18/2014Buy135,155$5.09$687,938.95View SEC Filing Icon  
8/14/2014Buy77,822$5.00$389,110.00View SEC Filing Icon  
8/13/2014Buy29,435$4.93$145,114.55View SEC Filing Icon  
8/12/2014Buy123,423$4.89$603,538.47View SEC Filing Icon  
See Full Table

William W. Ericson Buying and Selling Activity at Pacific Biosciences of California

This chart shows William W Ericson's buying and selling at Pacific Biosciences of California by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pacific Biosciences of California Company Overview

Pacific Biosciences of California logo
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Read More

Today's Range

Now: $3.81
Low: $3.68
High: $3.89

50 Day Range

MA: $5.45
Low: $3.52
High: $7.40

2 Week Range

Now: $3.81
Low: $3.45
High: $14.55

Volume

3,948,282 shs

Average Volume

8,764,740 shs

Market Capitalization

$1.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.87